Biliary Atresia: New Developments

  • Filippo Parolini
  • Mark Davenport


This chapter is based upon an invited lecture for the Symposium of Neonatal Surgery on 24th–25th October 2016 in Bologna, Italy. Biliary atresia is a “congenital” disorder of the biliary tree characterized by progressive fibrosing obstruction and presenting as conjugated jaundice and pale stools in the first weeks of life. The true aetiology is largely unknown, although embryological and infective hypotheses have been suggested. Treatment is entirely surgical being an attempt to restore bile flow and salvage of the native liver in the first instance (Kasai portoenterostomy) reserving liver transplantation for those where this approach is unsuccessful.


Biliary atresia Liver transplantation Kasai portoenterostomy Aetiology Bile duct development 


  1. 1.
    Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704–13.CrossRefGoogle Scholar
  2. 2.
    Livesey E, Cortina Borja M, Sharif K, Alizai N, McClean P, Kelly D, Hadzic N, Davenport M. Epidemiology of biliary atresia in England and Wales (1999–2006). Arch Dis Child Fetal Neonatal Ed. 2009;94:F451–5.CrossRefGoogle Scholar
  3. 3.
    Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis. 2013;8:128.CrossRefGoogle Scholar
  4. 4.
    Sokol RJ, Mack C, Narkewicz MR, et al. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003;37:4–21.CrossRefGoogle Scholar
  5. 5.
    Superina R, Magee JC, Brandt ML, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg. 2011;254:577–85.CrossRefGoogle Scholar
  6. 6.
    Davenport M, Ong E, Sharif K, Alizai N, McClean P, Hadzic N, Kelly DA. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg. 2011;46:1689–94.CrossRefGoogle Scholar
  7. 7.
    Kasai M, Sawaguchi S, Akiyama T, et al. A proposal of new classification of biliary atresia. J Jpn Soc Pediatr Surg. 1976;12:327–33.Google Scholar
  8. 8.
    Govindarajan KK. Biliary atresia: where do we stand now? World J Hepatol. 2016;8(36):1593–601.CrossRefGoogle Scholar
  9. 9.
    Nio M, Wada M, Sasaki H, Tanaka H, Watanabe T. Long-term outcomes of biliary atresia with splenic malformation. J Pediatr Surg. 2015;50(12):2124–7.CrossRefGoogle Scholar
  10. 10.
    Davenport M, Tizzard SA, Underhill J, Mieli-Vergani G, Portmann B, Hadzić N. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr. 2006;149(3):393–400.CrossRefGoogle Scholar
  11. 11.
    Caponcelli E, Knisely AS, Davenport M. Cystic biliary atresia: an etiologic and prognostic subgroup. J Pediatr Surg. 2008;43:1619–24.CrossRefGoogle Scholar
  12. 12.
    Zani A, Quaglia A, Hadzić N, Zuckerman M, Davenport M. Cytomegalovirus-associated biliary atresia: an aetiological and prognostic subgroup. J Pediatr Surg. 2015;50(10):1739–45.CrossRefGoogle Scholar
  13. 13.
    Davenport M. Biliary atresia: from Australia to the zebrafish. J Pediatr Surg. 2016;51(2):200–5.CrossRefGoogle Scholar
  14. 14.
    Makin E, Quaglia A, Kvist N, Petersen BL, Portmann B, Davenport M. Congenital biliary atresia: liver injury begins at birth. J Pediatr Surg. 2009;44(3):630–3.CrossRefGoogle Scholar
  15. 15.
    Davit-Spraul A, Baussan C, Hermeziu B, Bernard O, Jacquemin E. CFC1 gene involvement in biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr. 2008;46(1):111–2.CrossRefGoogle Scholar
  16. 16.
    Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst – the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg. 1974;6:113–39.PubMedGoogle Scholar
  17. 17.
    Saito T, Terui K, Mitsunaga T, Nakata M, Ono S, Mise N, Yoshida H. Evidence for viral infection as a causative factor of human biliary atresia. J Pediatr Surg. 2015;50:1398–404.CrossRefGoogle Scholar
  18. 18.
    Rauschenfels S, Krassmann M, Al-Masri AN, et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr. 2009;168:469–76.CrossRefGoogle Scholar
  19. 19.
    Hill R, Quaglia A, Hussain M, Hadzic N, Mieli-Vergani G, Vergani D, Davenport M. Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg. 2015;50(8):1297–303.CrossRefGoogle Scholar
  20. 20.
    Fischler B, Casswall TH, Malmborg P, Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr. 2002;34:154–7.CrossRefGoogle Scholar
  21. 21.
    Shah I, Bhatnagar S. Biliary atresia with cytomegalovirus infection and its response to ganciclovir. Trop Gastroenterol. 2014;35(1):56–8.CrossRefGoogle Scholar
  22. 22.
    Davenport M, Gonde C, Redkar R, Koukoulis G, Tredger M, Mieli-Vergani G, Portmann B, Howard ER. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg. 2001;36(7):1017–25.CrossRefGoogle Scholar
  23. 23.
    Davenport M, Gonde C, Narayanaswamy B, Mieli-Vergani G, Tredger JM. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J Pediatr Surg. 2005;40(9):1464–9.CrossRefGoogle Scholar
  24. 24.
    Shen O, Sela HY, Nagar H, Rabinowitz R, Jacobovich E, Chen D, Granot E. Prenatal diagnosis of biliary atresia: a case series. Early Hum Dev. 2017;19(111):16–9.CrossRefGoogle Scholar
  25. 25.
    Ng J, Paul A, Wright N, Hadzic N, Davenport M. Vitamin D levels in infants with biliary atresia: pre- and post-Kasai portoenterostomy. J Pediatr Gastroenterol Nutr. 2016;62(5):746–50.CrossRefGoogle Scholar
  26. 26.
    Grieve A, Makin E, Davenport M. Aspartate aminotransferase-to-platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation. J Pediatr Surg. 2013;48(4):789–95.CrossRefGoogle Scholar
  27. 27.
    Suominen JS, Lampela H, Heikkilä P, Lohi J, Jalanko H, Pakarinen MP. APRi predicts native liver survival by reflecting portal fibrogenesis and hepatic neovascularization at the time of portoenterostomy in biliary atresia. J Pediatr Surg. 2015;50:1528–31.CrossRefGoogle Scholar
  28. 28.
    Kianifar HR, Tehranian S, Shojaei P, et al. Accuracy of hepatobiliary scintigraphy for differentiation of neonatal hepatitis from biliary atresia: systematic review and meta-analysis of the literature. Pediatr Radiol. 2013;43(8):905–19.CrossRefGoogle Scholar
  29. 29.
    Russo P, Magee JC, Anders RA, Bove KE, et al. Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: a multicenter study. Am J Surg Pathol. 2016;40:1601–15.CrossRefGoogle Scholar
  30. 30.
    Matsui A, Ishikawa T. Identification of infants with biliary atresia in Japan. Lancet. 1994;343:925.CrossRefGoogle Scholar
  31. 31.
    Lien TH, Chang MH, Wu JF, Chen HL, Lee HC, Chen AC, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology. 2011;53:202–8.CrossRefGoogle Scholar
  32. 32.
    Wildhaber BE. Screening for biliary atresia: Swiss stool color card. Hepatology. 2011;54:367–8.CrossRefGoogle Scholar
  33. 33.
    Schreiber RA, Masucci L, Kaczorowski J, Collet JP, Lutley P, Espinosa V, Bryan S. Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis. J Med Screen. 2014;21(3):126–32.CrossRefGoogle Scholar
  34. 34.
    Verkade HJ, Bezerra JA, Davenport M, et al. Biliary atresia and other cholestatic childhood diseases: advances and future challenges. J Hepatol. 2016;65(3):631–42.CrossRefGoogle Scholar
  35. 35.
    Franciscovich A, Vaidya D, Doyle J, et al. PoopMD, a mobile health application, accurately identifies infant acholic stools. PLoS One. 2015;10:e0132270.CrossRefGoogle Scholar
  36. 36.
    Esteves E, Clemente Neto E, Ottaiano Neto M, Devanir J Jr, Esteves Pereira R. Laparoscopic Kasai portoenterostomy for biliary atresia. Pediatr Surg Int. 2002;18(8):737–40.PubMedGoogle Scholar
  37. 37.
    Dutta S, Woo R, Albanese CT. Minimal access portoenterostomy: advantages and disadvantages of standard laparoscopic and robotic techniques. J Laparoendosc Adv Surg Tech A. 2007;17(2):258–64.CrossRefGoogle Scholar
  38. 38.
    Chan KW, Lee KH, Wong HY, Tsui SY, Wong YS, Pang KY, Mou JW, Tam YH. From laparoscopic to open Kasai portoenterostomy: the outcome after reintroduction of open Kasai portoenterostomy in infant with biliary atresia. Pediatr Surg Int. 2014;30(6):605–8.CrossRefGoogle Scholar
  39. 39.
    Ure BM, Kuebler JF, Schukfeh N, Engelmann C, Dingemann J, Petersen C. Survival with the native liver after laparoscopic versus conventional Kasai portoenterostomy in infants with biliary atresia: a prospective trial. Ann Surg. 2011;253(4):826–30.CrossRefGoogle Scholar
  40. 40.
    Lishuang M, Zhen C, Guoliang Q, Zhen Z, Chen W, Long L, Shuli L. Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and meta-analysis of comparative studies. Pediatr Surg Int. 2015;31(3):261–9.CrossRefGoogle Scholar
  41. 41.
    Yamataka A. Laparoscopic Kasai portoenterostomy for biliary atresia. J Hepatobiliary Pancreat Sci. 2013;20(5):481–6.CrossRefGoogle Scholar
  42. 42.
    Wada M, Nakamura H, Koga H, Miyano G, Lane GJ, Okazaki T, Urao M, Murakami H, Kasahara M, Sakamoto S, Ishizaki Y, Kawasaki S, Yamataka A. Experience of treating biliary atresia with three types of portoenterostomy at a single institution: extended, modified Kasai, and laparoscopic modified Kasai. Pediatr Surg Int. 2014;30(9):863–70.CrossRefGoogle Scholar
  43. 43.
    Karrer FM, Lilly JR. Corticosteroid therapy in biliary atresia. J Pediatr Surg. 1985;20:693–5.CrossRefGoogle Scholar
  44. 44.
    Miner PB Jr, Gaito JM. Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard. Biochem Pharmacol. 1979;28:1063–6.CrossRefGoogle Scholar
  45. 45.
    Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebo controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46:1821–7.CrossRefGoogle Scholar
  46. 46.
    Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311:1750–9.CrossRefGoogle Scholar
  47. 47.
    Davenport M, Parsons C, Tizzard S, et al. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol. 2013;59:1054–8.CrossRefGoogle Scholar
  48. 48.
    Tyraskis A, Davenport M. Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int. 2016;32:193–2.CrossRefGoogle Scholar
  49. 49.
    Willot S, Uhlen S, Michaud L, Briand G, et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics. 2008;122:e1236–41.CrossRefGoogle Scholar
  50. 50.
    Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43(1):38.CrossRefGoogle Scholar
  51. 51.
    Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25.CrossRefGoogle Scholar
  52. 52.
    Ng VL, Haber BH, Magee JC, Miethke A, et al. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr. 2014;165(3):539–546.e2.CrossRefGoogle Scholar
  53. 53.
    Decharun K, Leys CM, West KW, Finnell SM. Prophylactic antibiotics for prevention of cholangitis in patients with biliary atresia status post-Kasai portoenterostomy: a systematic review. Clin Pediatr (Phila). 2016;55:66–72.CrossRefGoogle Scholar
  54. 54.
    Shalaby A, Makin E, Davenport M. Portal venous pressure in biliary atresia. J Pediatr Surg. 2012;47(2):363–6.CrossRefGoogle Scholar
  55. 55.
    Duché M, Ducot B, Ackermann O, Guérin F, Jacquemin E, Bernard O. Portal hypertension in children: high-risk varices, primary prophylaxis and consequences of bleeding. J Hepatol. 2017;66(2):320–7.CrossRefGoogle Scholar
  56. 56.
    Isted A, Grammatikopoulos T, Davenport M. Prediction of esophageal varices in biliary atresia: derivation of the “varices prediction rule”, a novel non-invasive predictor. J Pediatr Surg. 2015;50(10):1734–8.CrossRefGoogle Scholar
  57. 57.
    Heaton ND, Davenport M, Howard ER. Incidence of haemorrhoids and anorectal varices in children with portal hypertension. Br J Surg. 1993;80(5):616–8.CrossRefGoogle Scholar
  58. 58.
    Hadžić N, Quaglia A, Portmann B, et al. Hepatocellular carcinoma in biliary atresia: King’s College Hospital experience. J Pediatr. 2011;159(4):617–22. e1CrossRefGoogle Scholar
  59. 59.
    Lampela H, Ritvanen A, Kosola S, Koivusalo A, Rintala R, Jalanko H, et al. National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scand J Gastroenterol. 2012;47:99–107.CrossRefGoogle Scholar
  60. 60.
    Kvist N, Davenport M. Thirty-four years’ experience with biliary atresia in Denmark: a single center study. Eur J Pediatr Surg. 2011;21(4):224–8.CrossRefGoogle Scholar
  61. 61.
    Wildhaber BE, Majno P, Mayr J, Zachariou Z, Hohlfeld J, Schwoebel M, Kistler W, Meuli M, Le Coultre C, Mentha G, Belli D, Chardot C. Biliary atresia: Swiss national study, 1994–2004. J Pediatr Gastroenterol Nutr. 2008;46(3):299–307.CrossRefGoogle Scholar
  62. 62.
    Shreiber RA, Barker CC, Roberts EA, Martin SR, Canadian Pediatric Hepatology Research Group. Biliary atresia in Canada: the effect of centre caseload experience on outcome. J Pediatr Gastroenterol Nutr. 2010;51:61–5.CrossRefGoogle Scholar
  63. 63.
    Tu CG, Khurana S, Couper R, Ford AW. Kasai hepatoportoenterostomy in South Australia: a case for ‘centralized decentralization’. ANZ J Surg. 2015;85:865–8.CrossRefGoogle Scholar
  64. 64.
    Chardot C, Buet C, Serinet MO, Golmard JL, Lachaux A, Roquelaure B, Gottrand F, Broué P, Dabadie A, Gauthier F, Jacquemin E. Improving outcomes of biliary atresia: French national series 1986–2009. J Hepatol. 2013;58(6):1209–17.CrossRefGoogle Scholar
  65. 65.
    de Vries W, de Langen ZJ, Groen H, Scheenstra R, Peeters PM, Hulscher JB, Verkade HJ, Netherlands Study Group of Biliary Atresia and Registry (NeSBAR). Biliary atresia in the Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr. 2012;160(4):638–644.e2.CrossRefGoogle Scholar
  66. 66.
    Leonhardt J, Kuebler JF, Leute PJ, Turowski C, Becker T, Pfister ED, et al. Biliary atresia: lessons learned from the voluntary German registry. Eur J Pediatr Surg. 2011;21:82–7.CrossRefGoogle Scholar
  67. 67.
    Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467–74.CrossRefGoogle Scholar
  68. 68.
    Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K, Japanese Biliary Atresia Registry. Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg. 2003;38(7):997–1000.CrossRefGoogle Scholar
  69. 69.
    Petersen C, Madadi-Sanjani O. Registries for biliary atresia and related disorders. Eur J Pediatr Surg. 2015;25(6):469–73.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Filippo Parolini
    • 1
  • Mark Davenport
    • 1
  1. 1.Department of Paediatric SurgeryKings College HospitalLondonUK

Personalised recommendations